EML4-ALK Fusion Is Linked to Histological Characteristics in a Subset of Lung Cancers

This publication has 27 references indexed in Scilit:

• HOXB2 as a Novel Prognostic Indicator for Stage I Lung Adenocarcinomas
  Journal of Thoracic Oncology, 2007
• Up-regulation of PTEN at the transcriptional level is an adverse prognostic factor in female lung adenocarcinomas
  Lung Cancer, 2007
• Identification of the transforming EML4–ALK fusion gene in non-small-cell lung cancer
  Nature, 2007
• Human EML4, a novel member of the EMAP family, is essential for microtubule formation
  Experimental Cell Research, 2006
• Two subclasses of lung squamous cell carcinoma with different gene expression profiles and prognosis identified by hierarchical clustering and non-negative matrix factorization
  Oncogene, 2005
• Clinical and Biological Features Associated With Epidermal Growth Factor Receptor Gene Mutations in Lung Cancers
  JNCI Journal of the National Cancer Institute, 2005
• EGF receptor gene mutations are common in lung cancers from “never smokers” and are associated with sensitivity of tumors to gefitinib and erlotinib
  Proceedings of the National Academy of Sciences, 2004
• EGFR Mutations in Lung Cancer: Correlation with Clinical Response to Gefitinib Therapy
  Science, 2004
• Activating Mutations in the Epidermal Growth Factor Receptor Underlying Responsiveness of Non–Small-Cell Lung Cancer to Gefitinib
  New England Journal of Medicine, 2004
• Fusion of a Kinase Gene, ALK , to a Nucleolar Protein Gene, NPM , in Non-Hodgkin's Lymphoma
  Science, 1994